| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Financial Officer
1 company
Ian Michael Estepan is Chief Operating Officer at SRPT. Ian Michael Estepan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.3M at current prices.
Our model assigns Ian Michael Estepan a strong insider score of 75/100, based on 3 past trades. Over a 12-month horizon, both of those trades were profitable, with an average 12-month return of +51.8%.
The SRPT filings lean toward selling, a net 20,372 shares.
Ian Michael Estepan has 29 Form 4 filings on record from December 2020 to September 2026, all as Chief Operating Officer at Sarepta Therapeutics (SRPT), 2020–2026.
The 55 reported transactions were 25 tax withholdings, 11 option or other derivative awards, 8 option exercises and 7 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.3M.
The largest open-market sale was 5,985 shares of SRPT at an average $137.36 on August 30, 2024, about $822K. Twelve months later SRPT was down 87%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | SRPT Sarepta Therapeutics, Inc. | Chief Operating Officer | Sell | 13,187 | $22.31 | $294,201.97 | -6.4% | -25.3% | - | |
| Aug 30, 2024 | SRPT Sarepta Therapeutics, Inc. | Chief Financial Officer | Sell | 5,985 | $137.36 | $822,099.60 | -15.0% | -1.8% | -86.6% | |
| Mar 1, 2024 | SRPT Sarepta Therapeutics, Inc. | Chief Financial Officer | Sell | 1,200 | $128.30 | $153,960.00 | -3.0% | -3.3% | -17.0% |